Records containing: Non-Alcoholic Fatty Liver Disease
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-08-19Mediterranean Diet in Familial Mediterranean Fever: Is Fatty Liver Affected by Addition of Elliptical Aerobic Exercise
-
CLINICAL_TRIALS study record update · 2025-08-14Effect of Alpha Lipoic Acid on Non-alcoholic Fatty Liver Diseases: A Randomized Placebo-controlled Clinical Trial
-
CLINICAL_TRIALS study record update · 2025-08-07InAdvance: Surveillance, Prevention, and Interception in a Population at Risk For Cancer
-
CLINICAL_TRIALS study record update · 2025-08-03A 52-Week, Phase 3, Open-Label Extension Study, With a Double-blind Lead-in, to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE)
-
CLINICAL_TRIALS study record update · 2025-08-01A Clinical Study on the Effect of Adjustable Intragastric Balloon in Obese Patients With Non Alcoholic Fatty Liver Disease(NAFLD) or Non-Alcoholic Steatohepatitis (NASH) With or Without Diabetes Mellitus
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-07-22Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity-Associated Diseases
-
CLINICAL_TRIALS study record update · 2025-07-09The Investigation of Different Guidance Methods to Facilitate Lifestyle Changes in Patients With NAFLD
-
CLINICAL_TRIALS study record update · 2025-07-09Study of the Characteristics of Non-Alcoholic Fatty Liver Disease (NAFLD) in Type 2 Diabetes Mellitus Patients Followed in a Hospital Environment in Flanders, Belgium
-
CLINICAL_TRIALS study record update · 2025-07-02Body Composition and Metabolic Manifestations of Insulin Resistance in Adolescents With Polycystic Ovary Syndrome: Ectopic Fat Deposition and Metabolic Markers: Intervention and Follow-up Portion
-
CLINICAL_TRIALS study record update · 2025-06-25Accuracy of Imaging Techniques Including Ultrasound and Magnetic Resonance Imaging in the Diagnosis of Steatohepatitis and Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease: Comparison With the Histological Reference Standard
-
CLINICAL_TRIALS study record update · 2025-06-19Liver Health and Metabolic Function in People With Obesity
-
CLINICAL_TRIALS study record update · 2025-06-18Assesment of Liver Functions in Women With Polycystic Ovary Syndrome Using Fibroscan
-
CLINICAL_TRIALS study record update · 2025-06-13Influence of the Diversity and Composition of the Microbiota in the Development of Pediatric Fatty Liver: Identification of Biomarkers and Development of Personalized Therapy: The MicroKid Project
-
CLINICAL_TRIALS study record update · 2025-06-03Investigating Pathological Mechanisms in Non-alcoholic Fatty Liver Disease: Cross-sectional Comparative Study Between Patients and Healthy Controls
-
CLINICAL_TRIALS study record update · 2025-05-20Moderately Carbohydrate-restricted Diet as Treatment Targeting Improvement in Hepatic Lipid and Insulin Sensitivity in Adolescents With NAFLD
-
CLINICAL_TRIALS study record update · 2025-04-22Primary Care Screening to Rapidly Detect Multi-organ Complications for People With Prediabetes and Type 2 Diabetes
-
CLINICAL_TRIALS study record update · 2025-04-18A 6-Month, Randomized, Double-Blind, Placebo-controlled, Phase 2 Study of the Safety and Efficacy of Three HU6 Dose Levels and Placebo in Nonalcoholic Steatohepatitis
-
CLINICAL_TRIALS study record update · 2025-04-01A Randomized Controlled Trial of Effects of DAIry PROtein Products on Liver Disease Severity and Metabolism in Patients With Non-Alcoholic Fatty Liver Disease.
-
CLINICAL_TRIALS study record update · 2025-03-30Effectiveness of Long-term Low-frequency High-Intensity Interval Training (HIIT) to Improve Body Adiposity and Liver Fat in Adults With Central Obesity: A Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2025-03-28Liver Steatosis in Pediatric Celiac Disease Patients: Exploring the Epidemiological and Pathophysiological Features of an Underestimated Condition
-
CLINICAL_TRIALS study record update · 2025-03-24Nonalcoholic Steatohepatitis in Chinese Children: a Long Term Follow-up
-
CLINICAL_TRIALS study record update · 2025-03-18Evaluating the Safety and Efficacy of Carbocisteine in the Treatment of Nonalcoholic Fatty Liver Disease Patients
-
CLINICAL_TRIALS study record update · 2025-03-17Clinical Observation of the Effect of Ursodeoxycholic Acid on Parameters Affecting Liver, Metabolic and Cardiovascular Morbidity and Mortality - Pilot Project
-
CLINICAL_TRIALS study record update · 2025-03-13AdventHealth Research Institute Non-Alcoholic Fatty Liver Disease Biobank and Registry (AVAIL)
-
CLINICAL_TRIALS study record update · 2025-03-05Comparison of The Effects of Thiazolidinediones(TZD), Sodium- Glucose Cotransporter 2 Inhibitors(SGLT2i) Alone and TZD / SGLT2i Combination Therapy on Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients With Type 2 Diabetes